{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:40:14Z","timestamp":1793652014671,"version":"4.5.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The incidence and prevalence of AAV in Asia remain poorly understood, especially in a nationwide setting. This study investigated the incidence, prevalence, and healthcare burden of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in South Korea by analyzing a national database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included patients with AAV identified from the National Health Insurance Service Database of South Korea from 2002 to 2018. Patients were diagnosed with AAV in a general or tertiary hospital and were registered in the individual payment beneficiaries program or were prescribed glucocorticoids. A calendar-based meteorological definitions were adopted to assess the differences in the incidence of AAV according to season. The average healthcare expenditure and patient outcomes of mortality and end-stage renal disease (ESRD) in patients with AAV were compared to 1:10 age, sex and residential area matched controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2,113 patients [708, 638, and 767 with microscopic polyangiitis (MPA), granulomatosis with polyangiitis, and eosinophilic granulomatosis with polyangiitis, respectively] were identified. The annual incidence and prevalence of AAV increased continuously, and MPA being the most common disease subtype after 2015. The highest incidence and prevalence of AAV was 0.48\/100,000 person-years (PY) and 2.40\/100,000 PY in 2017 and 2018, respectively. There were no significant differences in monthly and seasonal incidence of AAV. The average expense of medical care, overall mortality, and ESRD rates of patients with AAV were higher in patients with AAV than in controls, especially in the case of MPA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>An increasing trend of AAV diagnosis observed is consistent with the evidence that AAV is more common in recent years; however, a relatively lower incidence and prevalence was observed compared to that in Western countries. The higher medical cost and rates of mortality and ESRD in AAV emphasize the early recognition and implementation of optimal treatment for these patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.902423","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T05:04:10Z","timestamp":1657170250000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002\u20132018 South Korea National Health Insurance Database"],"prefix":"10.3389","volume":"9","author":[{"given":"Sung Soo","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fimmu.2018.00680","article-title":"Pathogenetic and clinical aspects of anti-neutrophil cytoplasmic autoantibody-associated vasculitides","volume":"9","author":"Lamprecht","year":"2018","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.3389\/fimmu.2019.02855","article-title":"Personalized medicine in ANCA-associated vasculitis ANCA specificity as the guide?","volume":"10","author":"Wallace","year":"2019","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"m1070","DOI":"10.1136\/bmj.m1070","article-title":"ANCA associated vasculitis","volume":"369","author":"Hunter","year":"2020","journal-title":"BMJ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.berh.2018.09.001","article-title":"Update on the epidemiology, risk factors, and outcomes of systemic vasculitides","volume":"32","author":"Berti","year":"2018","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"624848","DOI":"10.3389\/fimmu.2021.624848","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis update: genetic pathogenesis","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"iii42","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An update on the epidemiology of ANCA-associated vasculitis","volume":"59","author":"Mohammad","year":"2020","journal-title":"Rheumatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3346\/jkms.2017.32.11.1764","article-title":"Using the national health information database of the national health insurance service in korea for monitoring mortality and life expectancy at national and local levels","volume":"32","author":"Bahk","year":"2017","journal-title":"J Korean Med Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson Comorbidity Index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.3346\/jkms.2019.34.e176","article-title":"The Incidences and Characteristics of various cancers in patients on dialysis: a Korean Nationwide Study","volume":"34","author":"Kwon","year":"2019","journal-title":"J Korean Med Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jmii.2013.12.006","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: a hospital-based study with reference to the population-based National Health Insurance database","volume":"48","author":"Wu","year":"2015","journal-title":"J Microbiol Immunol Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"B15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13075-018-1708-7","article-title":"The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China","volume":"20","author":"Li","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/1756-185X.13071","article-title":"Clinical features and long-term outcomes of 105 granulomatosis with polyangiitis patients: a single center experience from north India","volume":"21","author":"Sharma","year":"2018","journal-title":"Int J Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10067-020-05261-7","article-title":"Experience with similar biologic rituximab in 77 patients of granulomatosis with polyangiitis-a real-life experience","volume":"40","author":"Mittal","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/1756-185X.13398","article-title":"Is granulomatosis with polyangiitis in Asia different from the West?","volume":"22","author":"Naidu","year":"2019","journal-title":"Int J Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/art.24790","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?","volume":"61","author":"Gatenby","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e001555","DOI":"10.1136\/rmdopen-2020-001555","article-title":"ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study","volume":"7","author":"Aiyegbusi","year":"2021","journal-title":"RMD Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1185\/03007990903422307","article-title":"Societal cost of rheumatoid arthritis patients in the US","volume":"26","author":"Birnbaum","year":"2010","journal-title":"Curr Med Res Opin."},{"key":"B22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3899\/jrheum.191187","article-title":"Healthcare utilization and costs of systemic lupus erythematosus by disease severity in the United States","volume":"48","author":"Murimi-Worstell","year":"2021","journal-title":"J Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11739-020-02431-y","article-title":"Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases","volume":"16","author":"Quartuccio","year":"2021","journal-title":"Intern Emerg Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13075-015-0815-y","article-title":"Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study","volume":"17","author":"Sada","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ndt\/gfw046","article-title":"End-stage renal disease in ANCA-associated vasculitis","volume":"32","author":"Moiseev","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"i60","DOI":"10.1093\/ndt\/gfu392","article-title":"The long-term outcomes of systemic vasculitis","volume":"30","author":"Westman","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/art.40776","article-title":"Effect of disease activity at three and six months after diagnosis on long-term outcomes in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"71","author":"Gopaluni","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/art.39614","article-title":"Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease","volume":"68","author":"Rhee","year":"2016","journal-title":"Arthritis Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.902423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T05:04:11Z","timestamp":1657170251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.902423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":29,"alternative-id":["10.3389\/fmed.2022.902423"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.902423","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"article-number":"902423"}}